Sign in to fuzzto save your conversations, follow your research and come back anytime.
RPG Life Sciences
SectorHealthcare
| Metric (₹ crore) | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Sales | 172.71 | 143.09 | 168.92 | 181.68 | 180.03 | 176.89 | 195.69 |
| Expenses | 123.55 | 117.6 | 133.45 | 142.65 | 140.27 | 144.06 | 152.4 |
| EBITDA | 49.16 | 25.49 | 35.47 | 39.03 | 39.76 | 32.83 | 43.29 |
| Depreciation | 5.46 | 5.37 | 5.14 | 5.22 | 5.38 | 5.74 | 5.9 |
| EBIT | 43.7 | 20.12 | 30.33 | 33.81 | 34.38 | 27.09 | 37.39 |
| Interest | 0.12 | 0.18 | 0.13 | 0.12 | 0.25 | 0.39 | 0.63 |
| Profit Before Tax | 43.58 | 19.94 | 30.2 | 33.69 | 34.13 | 26.7 | 36.76 |
| Net Profit | 34.93 | 117.35 | 26.29 | 36.85 | 22.13 | 29.9 | 30.76 |
| EPS | 21.12 | 70.96 | 15.9 | 22.28 | 13.38 | 18.08 | 18.6 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Operating Cash Flow | 77.86 | 56.5 |
| Investing Cash Flow | -41.8 | 85.84 |
| Financing Cash Flow | -27.08 | -20.58 |
| Net Cash Flow | 8.98 | 121.76 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Equity / Shareholders' Funds | 530.53 | 605.35 |
| Total Liabilities | 127.28 | 187.81 |
| Total Assets | 657.81 | 793.16 |